Dr Alastair Lamb, the study author from the Cancer Research UK Cambridge institute said that their exciting outcome from the research shows that prostate cancer can be grouped into five genetically different types.
Advertisement
In order to identify more precisely which prostate cancer patients have more chances of growing and spreading their prostate tumors, researchers examined how 100 genes associated with prostate cancer acted in tumor samples.
Nice said too many Global Positioning System are “guessing” whether symptoms could mean cancer, with late diagnosis responsible for the deaths of up to 10,000 people each year.
A recent study revealed that prostate cancer is twice as likely to affect black men.
“The next step is to confirm these results in bigger studies and drill down into the molecular “nuts and bolts” of each specific prostate cancer type”.
In the meantime, we’re taking advantage of the summer sun (we hope!) and taking to the streets to spread awareness of black men’s increased risk of prostate cancer.
He also said that this research could be a game changer if the results give them better information to guide each man’s treatment.
“When they occur, diagnostic delays are largely due to cancer symptoms being extremely hard to distinguish from other diseases, combined with a lack of accurate and easy-to-use tests”.
But the difficulty in identifying the aggressive type means many men with the so-called “pussycat” form are subjected to painful and unnecessary treatments that can cause side-effects such as incontinence and impotence – and a few men with the more risky “tiger” version may not get the powerful drugs they need.
During the study, researchers observed cancer ridden prostate tissues from more than 250 men.
UK scientists have found that black men in England have double the risk of being both diagnosed with, and dying from, prostate cancer at a few point in their lives compared with white men.
Medical News Today recently reported that management of the disease seems to have improved, as mentioned by a recent study. For example, trouble passing urine is much more often caused by benign prostatic hyperplasia (BPH) than cancer.
Advertisement
The implications from the new data are positively leading experts to believe that they may be able to help more men and provide them with better options to treat aggressive cancers. Not only will the new discovery lead to more efficient treatments, but it will also enable better ways to predict just how prostate cancer will progress. Worldwide, it is the second most common cancer in men, behind lung cancer.
